<DOC>
	<DOCNO>NCT00420134</DOCNO>
	<brief_summary>The method separation mesenchymal stem cell establish 2001 . These cell differentiate osteocyte , hepatocytes , chondrocytes , myocytes etc , . In study investigator try separate mesenchymal stem cell end stage liver disease , cell differentiate progenitor hepatocytes , finally , investigator inject cell portal vein ultrasound guide . The investigator determine effect inject cell reestablishment liver function .</brief_summary>
	<brief_title>Improvement Liver Function Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection : Phase I-II Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<criteria>Inclusion criterion : MELD score least 10 Patent portal vein color Doppler examination liver Normal alphafeto protein serum level Age 18 Filling inform consent patient first degree family member Exclusion criterion : Any evidence hepatocellular carcinoma liver ultrasound study Patients want exclude study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>mesenchymal stem cell</keyword>
	<keyword>end stage liver disease</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>stem cell therapy</keyword>
</DOC>